Halozyme Therapeutics shares owned by Norden Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Norden Group
from 13F filings
Historical chart of Norden Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Norden Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Norden Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.3M | 28k | 47.81 |
| 2024-09-30 | $1.6M | 29k | 57.24 |
| 2024-06-30 | $868k | 17k | 52.36 |
| 2024-03-31 | $521k | 13k | 40.68 |
| 2023-12-31 | $323k | 8.7k | 36.96 |
| 2023-09-30 | $215k | 5.6k | 38.20 |